PHILADELPHIA, June 17, 2016 /PRNewswire/ -- CloudMine, healthcare's secure data platform, has released an iOS SDK (software development kit) designed to work with Apple's CareKit framework. Built to support native iOS apps, this SDK will communicate with CloudMine's Connected Health Cloud.
CloudMine's Connected Health Cloud complements the CareKit framework to provide secure storage for data generated by CareKit apps. CloudMine's SDK also provides CareKit app developers with HIPAA compliance, end-to-end encryption, user management & authentication, clinical systems connectivity (including electronic health records or "EHR"), and streamlined access to SMS/text & push notifications. The CareKit SDK will be part of CloudMine's existing CMHealth SDK, which includes support for Apple ResearchKit to power mobile clinical trials and survey-based engagement.
"Digital health is about empowering patients through understanding and engagement," said Brendan McCorkle, CEO of CloudMine. "CloudMine's CareKit software development kit provides healthcare organizations with the ability to deliver robust iOS applications to understand and engage through storing sensitive patient data and gaining key insights from the context of patient life."
CloudMine successfully raised a Series A totaling $7.25 million in 2015, led by Safeguard Scientifics. The company also saw revenue growth triple over the year, landed several landmark clients, and more than doubled headcount.
About CloudMine CloudMine provides the only secure, cloud-based digital health platform that helps healthcare organizations connect to the world of healthcare data, promote patient engagement, and ultimately improve quality of care. Through CloudMine, technology is available today that makes delivering accurate, personalized and intelligent health solutions within reach for all parties in the healthcare chain, from hospitals and pharmaceutical companies to life science and biotech startups. CloudMine's Connected Health Cloud is being used by world-class enterprises including Thomas Jefferson University Hospitals, Biomeme, Mylan Specialty, Endo Pharmaceuticals, Barnes & Noble College and Digitas Health.